Investor agreement for Alzheimer's immunotherapy programInvestor Agreement • December 1st, 2022 • New York
Contract Type FiledDecember 1st, 2022 JurisdictionINVESTMENT AGREEMENT, dated as of September 17, 2009 (this “Agreement”), between Elan Corporation, plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Janssen Pharmaceutical, an Irish unlimited company (“Investor”).
Investor agreement for Alzheimer's immunotherapy programInvestor Agreement • December 1st, 2022 • New York
Contract Type FiledDecember 1st, 2022 JurisdictionINVESTMENT AGREEMENT, dated as of September 17, 2009 (this “Agreement”), between Elan Corporation, plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Janssen Pharmaceutical, an Irish unlimited company (“Investor”).